Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients.

@article{Fazio2009ToleranceSA,
  title={Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicentre postmarketing study in 9657 patients.},
  author={Sharon Fazio and Jorge Pouso and Deyanira Dolinsky and Antonio Fern{\'a}ndez and Mariola Hern{\'a}ndez and Gilles Clavier and Matthias Hecker},
  journal={Phytomedicine : international journal of phytotherapy and phytopharmacology},
  year={2009},
  volume={16 1},
  pages={17-24}
}
In this postmarketing study 9657 patients (5181 children) with bronchitis (acute or chronic bronchial inflammatory disease) were treated with a syrup containing dried ivy leaf extract. After 7 days of therapy, 95% of the patients showed improvement or healing of their symptoms. The safety of the therapy was very good with an overall incidence of adverse events of 2.1% (mainly gastrointestinal disorders with 1.5%). In those patients who got concomitant medication as well, it could be shown that… CONTINUE READING

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations

Similar Papers

Loading similar papers…